Dec 04, 2019
Monumental Treatment Breakthrough for Lupus Kidney Disease
Nov 26, 2019
Lupus Research Alliance 2019 Breaking Through Gala Raises $3 Million for Lupus Research
Nov 15, 2019
RemeGen, Ltd. Announces Positive Results from Phase IIb Clinical Trial in Systemic Lupus Erythematosus
Nov 11, 2019
New data shows benefit of lupus drug
Nov 11, 2019
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
Nov 10, 2019
Leader in Lupus Research and Young Investigator Recognized for Exceptional Contributions and Dedication to Field
Nov 10, 2019
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
Nov 05, 2019
Lupus Foundation of America Announces Development of Next Generation Data Platform to Advance Lupus Research
Oct 24, 2019
Lupus Research Alliance Announces 2019 Distinguished Innovator Awards Aimed at New Lupus Treatments
Oct 24, 2019
GSK announces new events in the "Us in Lupus" campaign to reach women of color
Sep 25, 2019
Lupus Research Award Supports Early Career Scientists, Funds Study Areas of Critical Need
Sep 20, 2019
Global Lupus Nephritis (LN) Report 2019 - Market Insights, Epidemiology and Market Forecast to 2028
Sep 10, 2019
Los Angeles Comes Together to Be Powerful and Walk to End Lupus Now
Sep 09, 2019
The Life Sciences Division Update Report on ImmuPharma plc Post AstraZeneca plc Announcement of Anifrolumab Successfully Navigating a Second Phase III Clinical Trial in Lupus
Aug 29, 2019
Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
Aug 27, 2019
Fellowship Program Awards Young Scientists, Paves Way for Future Lupus Researchers
Aug 08, 2019
Provention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in Lupus
Jul 25, 2019
Progentec Diagnostics Awarded SBIR Fast-Track Grant to Develop Immune Mediator-Based Blood Tests for Clinical Disease Activity in Lupus (SLE)
Jul 19, 2019
International Lupus Community Reaches First-Ever Agreement on Barriers to Research, Drug Development, Care and Access
Jul 18, 2019
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board of Directors